GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medico Remedies Ltd (NSE:MEDICO) » Definitions » Gross-Profit-to-Asset %

Medico Remedies (NSE:MEDICO) Gross-Profit-to-Asset % : 45.46% (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Medico Remedies Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Medico Remedies's annualized Gross Profit for the quarter that ended in Mar. 2024 was ₹437 Mil. Medico Remedies's average Total Assets over the quarter that ended in Mar. 2024 was ₹962 Mil. Therefore, Medico Remedies's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 45.46%.


Medico Remedies Gross-Profit-to-Asset % Historical Data

The historical data trend for Medico Remedies's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medico Remedies Gross-Profit-to-Asset % Chart

Medico Remedies Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.21 27.80 29.72 43.15 38.13

Medico Remedies Quarterly Data
Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 35.20 34.71 32.35 32.12 45.46

Competitive Comparison of Medico Remedies's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Medico Remedies's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medico Remedies's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medico Remedies's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Medico Remedies's Gross-Profit-to-Asset % falls into.



Medico Remedies Gross-Profit-to-Asset % Calculation

Medico Remedies's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Mar. 2024 )/( (Total Assets (A: Mar. 2023 )+Total Assets (A: Mar. 2024 ))/ count )
=350.141/( (874.483+961.953)/ 2 )
=350.141/918.218
=38.13 %

Medico Remedies's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=437.312/( (0+961.953)/ 1 )
=437.312/961.953
=45.46 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Medico Remedies Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Medico Remedies's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Medico Remedies (NSE:MEDICO) Business Description

Traded in Other Exchanges
Address
N. S. Phadke Marg, Opposite Teligali, 1105/1106, 11th Floor, Hubtown Solaris, Andheri (East), Mumbai, MH, IND, 400069
Medico Remedies Ltd is a manufacturer, supplier, and exporter of pharmaceutical drugs. It focuses on the production and marketing of anti-infective, cephalosporins, antimalarial, antiretroviral, anti-ulcer drugs and antacids, vitamins, haematinics, and other supplements. In addition, it also sells other drugs such as antihistaminic, antidiabetics, cardiovascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and cream, and gel for various therapeutic segments.

Medico Remedies (NSE:MEDICO) Headlines

No Headlines